Title : Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.

Pub. Date : 2000 May

PMID : 10871820






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 High dose combined docetaxel (50 mg/m2) and carboplatin (AUC4) chemotherapy can be safely administered on a two-weekly basis if supported with amifostine and GM-CSF. Docetaxel colony stimulating factor 2 Homo sapiens